Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Surged Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) climbed 6.5% on Wednesday after the European Commission granted a conditional marketing authorization (CMA) for its COVID-19 vaccine.

The CMA will allow the drug to be given to adults aged 18 and older throughout the European Union. To accelerate the rollout, the European Medicines Agency (EMA) ordered an additional 80 million doses of Moderna's vaccine, bringing its total order to 160 million doses. The first deliveries are scheduled to start next week.

Moderna scored another regulatory victory on Wednesday. Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share